{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:14:49Z","timestamp":1776928489094,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07521-2","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T12:06:58Z","timestamp":1717502818000},"page":"943-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Obstetric outcomes of patients with inflammatory bowel disease"],"prefix":"10.1007","volume":"310","author":[{"given":"Ambre","family":"Tondreau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coraline","family":"Breuval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Gondry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathurin","family":"Fumery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9017-6194","authenticated-orcid":false,"given":"Arthur","family":"Foulon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"7521_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4292\/wjgpt.v6.i4.156","volume":"6","author":"P Hosseini-Carroll","year":"2015","unstructured":"Hosseini-Carroll P, Mutyala M, Seth A, Nageeb S, Soliman D, Boktor M et al (2015) Pregnancy and inflammatory bowel diseases: current perspectives, risks and patient management. World J Gastrointest Pharmacol Ther 6:156\u2013171","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"7521_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S2468-1253(19)30358-9","volume":"5","author":"V Jairath","year":"2020","unstructured":"Jairath V, Feagan BG (2020) Global burden of inflammatory bowel disease. Lancet Gastroenterol Hepatol 5:2\u20133","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"15","key":"7521_CR3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/ecco-jcc\/jjab029","volume":"25","author":"M Zhao","year":"2021","unstructured":"Zhao M, G\u00f6nczi L, Lakatos PL, Burisch J (2021) The burden of inflammatory bowel disease in europe in 2020. J Crohns Colitis 25(15):1573\u20131587","journal-title":"J Crohns Colitis"},{"key":"7521_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.gcb.2009.07.005","volume":"33","author":"A Cortot","year":"2009","unstructured":"Cortot A, Pineton de Chambrun G, Vernier-Massouille G, Vigneron B, Gower RC (2009) Gastroenterol Clin Biol 33:681\u2013691","journal-title":"Gastroenterol Clin Biol"},{"key":"7521_CR5","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes J, Gower-Rousseau C, Seksik P, Cortot A (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterol 140:1785\u20131794","journal-title":"Gastroenterol"},{"key":"7521_CR6","unstructured":"Assurance Maladie. Personnes prises en charge pour maladies inflammatoires chroniques intestinales en 2019. CNAM\/DSES\/DEPP. 2021. [Internet]. Available on: http:\/\/www.observatoire-crohn-rch.fr\/wp-content\/uploads\/2021\/12\/2019_fiche_maladies-inflammatoires-chroniques-intestinales.pdf"},{"key":"7521_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/ibd.21120","volume":"16","author":"MB Bengtson","year":"2010","unstructured":"Bengtson MB, Solberg IC, Aamodt G, Jahnsen J, Moum B, Vatn MH (2010) Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring. Inflamm Bowel Dis 16:847\u2013855","journal-title":"Inflamm Bowel Dis"},{"key":"7521_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","volume":"15","author":"T Kucharzik","year":"2021","unstructured":"Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C et al (2021) ECCO Guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis 15:879\u2013913","journal-title":"J Crohns Colitis"},{"key":"7521_CR9","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1016\/S0002-9270(00)02083-9","volume":"95","author":"B Norgard","year":"2000","unstructured":"Norgard B, Fonager K, Sorensen HT, Olsen J (2000) Birth outcomes of women with ulcerative colitis: a nationwide danish cohort study. Am J Gastroenterol 95:3165\u20133170","journal-title":"Am J Gastroenterol"},{"key":"7521_CR10","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/ajg.2016.254","volume":"111","author":"A De Lima-Karagiannis","year":"2016","unstructured":"De Lima-Karagiannis A, Zelinkova-Detkova Z, van der Woude CJ (2016) The effects of active IBD during pregnancy in the era of novel IBD therapies. Am J Gastroenterol 111:1305\u20131312","journal-title":"Am J Gastroenterol"},{"key":"7521_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0020-7292(97)00088-X","volume":"58","author":"M Hudson","year":"1997","unstructured":"Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NAG (1997) Fertility and pregnancy in inflammatory bowel disease. Int J Gynecol Obstet 58:229\u2013237","journal-title":"Int J Gynecol Obstet"},{"key":"7521_CR12","first-page":"514","volume":"48","author":"A Foulon","year":"2020","unstructured":"Foulon A, Chevreau J, Yzet C, Gondry J, Fumery M (2020) IBD and pregnancy. Gynecol Obstet Fertil Senol 48:514\u2013519","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"7521_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S1297-9589(02)00003-6","volume":"31","author":"F Sergent","year":"2003","unstructured":"Sergent F, Verspyck E, Marpeau L (2003) Crohn\u2019s disease and pregnancy about 34 cases review of the literature. Gynecol Obstet Fertil 31:20\u201328","journal-title":"Gynecol Obstet Fertil"},{"key":"7521_CR14","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/BF02051924","volume":"33","author":"K Woolfson","year":"1990","unstructured":"Woolfson K, Cohen Z, McLeod RS (1990) Crohn\u02bcs disease and pregnancy. Dis Colon Rectum 33:869\u2013873","journal-title":"Dis Colon Rectum"},{"key":"7521_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/ecco-jcc\/jjaa225","volume":"15","author":"MA Kim","year":"2021","unstructured":"Kim MA, Kim YH, Chun J, Lee HS, Park SJ, Chean JH et al (2021) The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 15:719\u2013732","journal-title":"J Crohns Colitis"},{"key":"7521_CR16","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1007\/s10620-015-3677-x","volume":"60","author":"A O\u2019Toole","year":"2015","unstructured":"O\u2019Toole A, Nwanne O, Tomlinson T (2015) Inflammatory bowel disease increases risk of adverse pregnancy outcomes: a meta-analysis. Dig Dis Sci 60:2750\u20132761","journal-title":"Dig Dis Sci"},{"key":"7521_CR17","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.gastro.2007.07.019","volume":"133","author":"U Mahadevan","year":"2007","unstructured":"Mahadevan U, Sandborn WJ, Li D, Hakimian S, Kane S, Corley DA (2007) Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from northern california. Gastroenterology 133:1106\u20131112","journal-title":"Gastroenterology"},{"key":"7521_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/ibd.21369","volume":"17","author":"O Stephansson","year":"2011","unstructured":"Stephansson O, Larsson H, Pedersen L, Kieller H, Granath F, Ludvigsson JF et al (2011) Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in denmark and sweden. Inflamm Bowel Dis 17:795\u2013801","journal-title":"Inflamm Bowel Dis"},{"key":"7521_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.cgh.2010.02.014","volume":"8","author":"O Stephansson","year":"2010","unstructured":"Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF et al (2010) Crohn\u2019s disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol 8:509\u2013515","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7521_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/ibd\/izaa122","volume":"27","author":"KK Leung","year":"2021","unstructured":"Leung KK, Tandon P, Govardhanam V, Maxwell C, Huang V (2021) The risk of adverse neonatal outcomes with maternal inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 27:550\u2013562","journal-title":"Inflamm Bowel Dis"},{"key":"7521_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129567","volume":"10","author":"HA Boyd","year":"2015","unstructured":"Boyd HA, Basit S, Harps\u00f8e MC, Wohlfahrt J, Jess T (2015) Inflammatory bowel disease and risk of adverse pregnancy outcomes. PLoS ONE 10:e0129567","journal-title":"PLoS ONE"},{"key":"7521_CR22","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1007\/s10620-023-08016-x","volume":"68","author":"NB Patel","year":"2023","unstructured":"Patel NB, Vinsard DG, Kattah AG, Kane SV (2023) Decreased risk of preeclampsia in women with inflammatory bowel disease on anti-tumor necrosis factor therapy. Dig Dis Sci 68:3557\u20133561","journal-title":"Dig Dis Sci"},{"key":"7521_CR23","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/apt.16074","volume":"52","author":"A Meyer","year":"2020","unstructured":"Meyer A, Drouin J, Weill A, Carbonnel F, Dray-Spira R (2020) Pregnancy in women with inflammatory bowel disease: a french nationwide study 2010\u20132018. Aliment Pharmacol Ther 52:1480\u20131490","journal-title":"Aliment Pharmacol Ther"},{"key":"7521_CR24","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00404-023-06925-w","volume":"308","author":"R Jayawardena","year":"2023","unstructured":"Jayawardena R, Majeed S, Sooriyaarachchi P, Abeywarne U, Ranaweera P (2023) The effects of pyridoxine (vitamin B6) supplementation in nausea and vomiting during pregnancy: a systematic review and meta-analysis. Arch Gynecol Obstet 308:1075\u20131084","journal-title":"Arch Gynecol Obstet"},{"key":"7521_CR25","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s10620-012-2128-1","volume":"57","author":"S Hutfless","year":"2012","unstructured":"Hutfless S, Li DK, Heyman MB, Bayless TM, Abramson O, Herrinton LJ (2012) Prenatal and perinatal characteristics associated with pediatric-onset inflammatory bowel disease. Dig Dis Sci 57:2149\u20132156","journal-title":"Dig Dis Sci"},{"key":"7521_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjac115","volume":"17","author":"J Torres","year":"2022","unstructured":"Torres J, Chaparro M, Juksgaard M, Katsanos K, Zelinkova Z, Agrawal M et al (2022) European crohn\u2019s and colitis guidelines on sexuality, fertility, pregnancy, and lactation. J Crohns Colitis 17:1\u201327","journal-title":"J Crohns Colitis"},{"issue":"6","key":"7521_CR27","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00404-022-06463-x","volume":"306","author":"KD Allen","year":"2022","unstructured":"Allen KD, Kiefer MK, Butnariu M, Afzali A (2022) Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare. Arch Gynecol Obstet 306(6):1929\u20131937","journal-title":"Arch Gynecol Obstet"},{"key":"7521_CR28","unstructured":"Inserm. Enqu\u00eate natinale pr\u00e9inatale: r\u00e9sultats de l\u2019\u00e9dition 2021. Inserm. 2022. [Internet]. Available at: file:\/\/\/Users\/Downloads\/dp_ENP_2022.pdf"},{"key":"7521_CR29","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/MIB.0000000000001112","volume":"23","author":"A Foulon","year":"2017","unstructured":"Foulon A, Dupas JL, Sabbagh C, Chevreau J, Rebibo L, Fumery M (2017) Defining the most appropriate delivery mode in women with inflammatory bowel disease. Inflamm Bowel Dis 23:712\u2013720","journal-title":"Inflamm Bowel Dis"},{"key":"7521_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","volume":"4","author":"G Van Assche","year":"2010","unstructured":"Van Assche G, Dignass A, Reinisch W, Woude CJ, Sturm A (2010) De vos the second european evidence-based consensus on the diagnosis and management of crohn\u2019s disease: special situations. J Crohn\u2019s Colitis. 4:63\u2013101","journal-title":"J Crohn\u2019s Colitis."},{"key":"7521_CR31","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","volume":"150","author":"GC Nguyen","year":"2016","unstructured":"Nguyen GC, Seow CH, Maxwell C, Huang V, Leung Y, Jones J, Paterson W (2016) The toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology 150:734\u2013757","journal-title":"Gastroenterology"},{"key":"7521_CR32","first-page":"52","volume":"25","author":"R Khosla","year":"1984","unstructured":"Khosla R, Willoughby CP, Jewell DP (1984) Crohn\u2019s disease and pregnancy Gut 25:52\u201356","journal-title":"Crohn\u2019s disease and pregnancy Gut"},{"key":"7521_CR33","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2036.2011.04794.x","volume":"34","author":"A Bortoli","year":"2011","unstructured":"Bortoli A, Pedersen N, Duricova D, D\u2019Inca R, Gionchetti MR (2011) Pregnancy outcome in inflammatory bowel disease: prospective european case-control ECCO-EpiCom study, 2003\u20132006. Aliment Pharmacol Ther 34:724\u2013734","journal-title":"Aliment Pharmacol Ther"},{"key":"7521_CR34","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/apt.12417","volume":"38","author":"A Abhyankar","year":"2013","unstructured":"Abhyankar A, Ham M, Moss AC (2013) Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 38:460\u2013466","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07521-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07521-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07521-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T10:11:47Z","timestamp":1721297507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07521-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["7521"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07521-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3990548\/v1","asserted-by":"object"}]},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MF: Consulting\/lecture fees for Abbvie, Amgen, Arena, Biogen, Celtrion, CTMA, Galapagos, Janssen, MSD, Pfizer, Takeda, Fresenius-Kabi, Tillotts, MSD, Gilead, Celgene, Sandoz and Ferring. The remaining authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"IRB Ethical approval statement: Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}